Bone metastases and 3 or more sites of metastasis compared to distant lymph nodes only were also associated with lower odds of immunotherapy at academic than at nonacademic facilities. Survival Patients treated at high-volume and academic facilities were found to have lower overall risk-adjusted ...
Metastatic breast cancer was identified using ICD-9 diagnosis codes of 196.x to 198.x (excluding 198.2) and ICD-10 diagnosis codes of C77.x to C79.x (excluding C79.2). We classified patients as having metastatic breast cancer if at least 2 claims were found with these codes from 30 ...
A 44-year-old female patient was seen last week by her internist for a left breast mass. The patient was referred to an oncologist who ordered an MRI, which revealed intraductal carcinoma in situ left breast. Assign the correct ICD-10-CM codes to be ...
Table S1. SABR clinical characteristics (N = 32 patients included in the translational part), related to Figures 1 and 3 and STAR Methods Table S5. Patient characteristics in the ABIMMUNE trial, the ARTIC trial and the Firenze lung cancer cohort, related to Figure 3 and STAR Methods Documen...
Male patients aged ≥ 18 years with mCRPC were identified based on PC diagnosis code (ICD-9-CM: 185; ICD-10-CM: C61) during the study period, evidence of surgical/medical castration (defined in the appendix; similar to prior studies [25, 26] but with a shorter range for greater inclusi...
PC use was determined by the ICD-9-CM diagnostic code V66.7. This code was previously used and validated in metastatic disease with moderate sensitivity (ranges from 66.3 to 84.0%) and high specificity (ranges from 95.0 to 99.1%) [24,25]. Additionally, hospitals that had not ever provided...
From April 2008 to December 2022, we extracted the patients who were diagnosed with urothelial carcinoma by using ICD-10 codes. A total of around 239,685 urothelial cancer patients were extracted from this database, and 6007 were inducted with pembrolizumab. Regarding these patients, their age, ...
Administration of radium-223 and the prognosis in Japanese bone metastatic castration-resistant prostate cancer patients: A large database study. Int. J. Urol. 2022, 29, 1079–1084. [Google Scholar] [CrossRef] [PubMed] Challita-Eid, P.M.; Satpayev, D.; Yang, P.; An, Z.; Morrison...